Background Increasing activity in cholesterol lowering is placing increasing demands on lipid clinics to be able to cope with the increase in demand. A combination of interventions has been used to improve laboratory testing, focus interpretative results and provide educational and advisory facilities for general practitioners in order to increase shared care of many potential clinic patients.
Introduction
Several forces have combined to increase demand on laboratory services and hospital outpatient lipid clinic services, notably national and international guidance based on the landmark cholesterol-lowering trials, 1--3 the national service framework for preventing coronary heart disease in high-risk patients 4 and, more recently, the quality and outcomes framework of the general medical services contract. 5 Demands on secondary care management of lipid lowering have increased, and were locally compounded by a trust merger in 1997, which approximately doubled the original catchment population of the clinic and led to a further large rise in waiting times for appointments to the lipid clinic, which built up in the 18-month period before the initiative began in March 2001. This led to a successful pilot study to attempt to change the emphasis of how the service operated. 6 This rise has been mirrored by a 63% increase in the number of cholesterol measurements requested annually between 1999--2000 and 2003--04 in the laboratory serving the catchment area of the original clinic prior to the trust merger.
Large variations have been observed in general practitioner (GP) referral practices, 7 although changing referral practice has proved elusive. Improved communication between GPs and their consultant colleagues has been highlighted as a potential means of enabling change. 8 Guidelines alone are frequently poorly adhered to for various reasons, 9 and have limited e¡ect on testing and referral practices. 10 Several authors have concluded that the most e¡ective way to change clinicians' practice is to o¡er a combination of enabling and educational initiatives, at least in the ¢elds of test requesting. 10--12 It is important, however, that any initiative designed to bring bene¢t to a service is continued beyond the initial intensive introduction phase, and that it produces sustained long-term bene¢ts.
Di¡erences in testing practices, notably large variations in requesting for triglycerides between general practices, led locally to some diagnoses (e.g. diabetes, thyroid disease, alcohol misuse) being delayed in patients with abnormal cholesterol or triglyceride results, particularly in patients with less common lipid abnormalities. This had led to an earlier change in the laboratory request form to allow more focused and consistent laboratory testing and reporting of lipid parameters (total HDL cholestrol and calculated LDL cholesterol concentrations and triglyceride concentrations). 13 The subsequent pilot 6 was designed to change the manner in which outpatient referrals were handled. This involved promoting a written advisory service as a means of patient management in parallel to the clinic. GPs were encouraged to contact the service for speci¢c advice on patients, who otherwise might have been referred to be seen and were asked to provide clinical and laboratory details pertinent to the speci¢c question being asked. This required the referring GP to provide more detailed information on the patient, the speci¢c question being asked and notes of relevant past investigations. This process was supported by a series of short educational lunchtime meetings at individual practices, which were sponsored by pharmaceutical companies, but which were non-promotional in content.
Methods
In December 2004, copies of all advisory letters sent to GPs between March 2001 and September 2004 were obtained and examined retrospectively, categorizing the reasons for which advice was sought. Laboratory results were obtained in the period immediately before the referral letter until 15 months afterwards, and those available on patients closest in time to six months after the letter had been written were recorded and compared with results immediately before the advice had been sought. Practices were contacted by telephone to establish the review status of any patients, who did not have available results. The clinic secretary obtained monthly outpatient waiting times and numbers of new patients seen from the clinic bookings records and plotted these over the period 1999 (before the original pilot) until 2004. Total annual numbers of laboratory cholesterol requests, which are used as an indicator of overall activity in lipid management, were extracted from the laboratory computer system.
Results
A total of 520 referrals were received for appointments or advice over the period, 291 (56%) of which were handled by advisory letters to the referring GPs.
The case mix of patients handled by the advisory service was similar to the case mix which would traditionally have attended the clinic (90% were already receiving one or more lipid lowering therapies, and all of these had encountered problems with either success or tolerability of treatment, or with abnormal laboratory results on drug therapy).
The fall in waiting time reported over the initial 16month pilot 6 has been maintained over the three-anda-half-year period (Figure 1 ), except for occasional short-term increases which can be attributed to consultant leave.
Advisory letters were sent to GPs regarding a total of 291 patients: 174 of these recommended an active change to drug therapy or initiation of drug therapy; 52 were replies to speci¢c questions concerning drug safety or tolerability, mostly relating to liver or muscle enzyme rises; 34 recommended not treating the patient with lipid-lowering drugs; and 31 were other recommendations relating to management of dyslipidaemias related to poor diabetic control or advice on alcoholrelated lipid disorders. As would be expected in normal practice, an additional large (unrecorded) number of telephone calls and emails for advice were received, and were handled in the same manner before and after the service changes.
The GPs had followed up all except 14 of the 174 patients for whom addition or change of lipid-lowering drug therapy had been recommended. Most (12) of these patients had either decided with the doctor not to pursue cholesterol-lowering drug therapy, had moved home, or were pending GP review, but had not yet actually been seen. Only two had no planned review at the time of the audit. In all, 16 patients were subsequently referred back to the clinic as the original advice had not achieved a satisfactory result.
Median cholesterol and triglyceride concentrations in the 'active treatment advice' group of 174 patients are shown in Table 1 . LDL concentrations are not reported, as a large proportion of patients had raised triglycerides, making LDL cholesterol concentrations unreliable or invalid and in£uencing the total cholesterol concentrations (121 of the 174 had triglyceride concentrations over 2.3 mmol/L, and 69 over 4.5 mmol/L).
Discussion
Patient and practitioner perceptions and expectations play a signi¢cant part in the outcome of a consultation process. 14 Little, however, has been published on GP expectations of the referral process to secondary care. It would be normal 'good practice' for a consultant to examine referrals and o¡er advice if he/she felt that a clinic attendance was not necessary. However, information contained in referral letters can be sparse, particularly if the GP expectation is that a referred patient will receive an outpatient appointment, and it is often di⁄cult in practice to obtain the additional information needed to advise on a patient. A large proportion of patients referred are often therefore seen in clinic. The initiatives introduced were therefore designed to improve practitioners' knowledge of the conditions for which they were referring, improve the content of referral information and shift the balance of expectation more towards receiving advice in response to a referral rather than most patients receiving outpatient appointments.
GP follow-up of patients after they had received advice was very high (only two patients had no planned review at the time results were analysed), and only a small proportion (9%) were subsequently referred back to the clinic. The fall in median cholesterol and triglyceride concentrations after advice demonstrates a considerable improvement in this more complicated patient group, 90% of whom were already receiving lipid-lowering therapy or had stopped therapy because of tolerability problems. The high statistical signi¢cance is not surprising in the context, as it would have been disappointing if referral produced no demonstrable improvement. The high median triglyceride concentration (4.19 mmol/L) re£ects this more complex patient group, which contained a large number of patients with mixed hyperlipidaemias or hypertriglyceridaemia. It is not possible to compare these results against 'target' or other benchmark indicators, as this is a selected patient group in which a signi¢cant proportion of patients might not be expected to achieve conventional targets. A written 'advice only' service is in reality no more than a response to a letter from a GP, which would occur in everyday practice. The introduction of an advisory service was therefore simply an attempt to shift the GP expectation of the outcome of the referral process and increase the proportion of patients whose management could be supported by written advice rather than direct consultation. However, I believe the reason this means of management has been so readily adopted is due, at least in part, to actively promoting this as an alternative way of managing many patients without the expectation that most patients will be seen in a clinic.
While it is not possible to quantify the improvement in the content of referral letters, the information provided in referrals was su⁄cient to enable me to o¡er advice for the great majority of patients, where I considered this to be appropriate, reserving clinic appointments principally for patients with severe refractory lipid disorders or probable familial hyperlipidaemias. The proportion of patients managed by advice only has risen progressively during the three and a half years to 83% in the second quarter of 2004. The rise in total numbers of patients referred over the period is not surprising and is consistent with the rise in laboratory cholesterol testing, and possibly also with the removal of the long waiting time, which acts as an inappropriate and arti¢cial barrier to quite appropriate referral.
It was interesting to ¢nd that the initiatives introduced in 2001 had produced a sustained and increasing change in the manner of handling referrals. The series of outreach educational meetings appear to have contributed to this, although I can draw no absolute conclusions about this in the absence of a controlled trial. Two systematic reviews have, however, concluded that educational initiatives in general, 10 and outreach visits in particular, 15 can assist in changing doctors' practices, and I did not therefore consider it necessary or appropriate to run a control group of practices.
No di⁄culties were experienced in the changes being accepted by GPs locally, and the primary-care trusts have been most supportive. Feedback during the educational and other meetings has been very positive, and I did not therefore conduct a formal satisfaction survey. No additional resources have been needed apart from the sponsorship from the pharmaceutical companies for the meetings. The fall in new and returning patients to the clinic has allowed the advisory service and existing clinic to operate within the allocated time for the single clinic (1.5 programmed activities for clinical and supporting administrative work), but has approximately doubled the number of patients receiving either direct outpatient care or speci¢c advice to the GP. The only potential future threat to this service will be the impact of payment by results, 16 as the service does reduce the numbers of ¢nished consultant episodes, and therefore impacts on trust income. Hopefully, payment by results will contain su⁄cient £exibility in practice to permit this type of work to continue, to the mutual bene¢t of secondary and primary care trusts. The clinic now sees fewer patients than before the initiatives, patients are seen faster, and the case mix re£ects a more complex patient type in whom ¢rstand second-line treatments have failed, or who have more serious or complex dyslipidaemias.
The present advisory service operates mostly on the basis of exchange of typed correspondence sent by mail. Some practitioners have made use of email, coding the patient where necessary to avoid named patient details entering the Internet. Extension of this means of communication would potentially decrease the administrative time creating and ¢ling correspondence, particularly as it becomes increasingly possible to ¢le email reports automatically in patient records. The advent of teleconferencing has brought with it the possibility of envisaging a 'virtual' clinic with GPs or patients. The logistics and cost implications of this are considerable, and carry £exibility and availability constraints. While being technologically attractive, such an approach may not therefore be practical in this context.
The lipid clinic is a setting which lends itself to this type of change more than many others because of the close relationship between laboratory results and patient management. It would be interesting, however, to examine whether other areas of outpatient disease management might be candidates for similar initiatives, particularly those with a large reliance on programmed laboratory or other investigations. Do we need lipid clinics? Undoubtedly yes, although opportunities exist to shift the emphasis in the care they provide.
